Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.
| dc.contributor.author | Tuncer, Samuray | |
| dc.contributor.author | Basaran, Mert | |
| dc.contributor.author | Tanyildiz, Burak | |
| dc.contributor.author | Buyukbabani, Nesimi | |
| dc.contributor.author | Basaran, Gul | |
| dc.contributor.author | Dogan, Oner | |
| dc.date.accessioned | 2025-10-16T15:33:04Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, MAY 30-JUN 03, 2014 | |
| dc.identifier.doi | 10.1200/jco.2014.32.15\_suppl.e19503 | |
| dc.identifier.other | WOS:000358613201371 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/9208 | |
| dc.publisher | LIPPINCOTT WILLIAMS \& WILKINS | |
| dc.source | JOURNAL OF CLINICAL ONCOLOGY | |
| dc.title | Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience. | |
| dc.type | Meeting Abstract |